Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures
Biliary Stricture
About this trial
This is an interventional diagnostic trial for Biliary Stricture focused on measuring Biliary stricture, cholangioscopy
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years
- Patients presenting with obstructive jaundice with clinical suspicion for a biliary stricture based on imaging findings or during ERCP
- Written informed consent available
Exclusion Criteria:
- Contraindications for endoscopy due to comorbidities
- Unable to provide written informed consent
- Patients with clinical evidence of ongoing cholangitis precluding a safe cholangioscopy procedure
- Pregnant patients
- Moribund patients from terminal illnesses
Sites / Locations
- Prince of Wales Hospital, The Chinese University of Hong KongRecruiting
Arms of the Study
Arm 1
Experimental
SpyGlass DS Cholangioscopy
ERCP with cholangiogram will be performed to assess the common bile duct (CBD) and intrahepatic ducts (IHD) for presence of a stricture. Once a biliary stricture is confirmed on cholangiogram during ERCP, SpyGlass DS Cholangioscopy would be performed. The visual impression (VI) of the biliary stricture will be assessed. Tissue acquisition of the biliary stricture will be performed by cholangioscopy directed biopsy (CDBx), and conventional brush cytology with or without intraductal biopsy. Endoscopic stenting will be performed in standard fashion for biliary drainage to relieve the obstructive jaundice.